Top 5 Stock Picks of Eli Casdin’s Casdin Capital

Page 5 of 5

1. EQRx, Inc. (NASDAQ:EQRX)

Casdin Capital’s Stake Value: $185,385,000
Percentage of Casdin Capital’s 13F Portfolio: 15.67%
Number of Hedge Fund Holders: 26

EQRx, Inc. (NASDAQ:EQRX), a pharmaceutical company, develops pharmaceuticals primarily for the treatment of cancer and immune-inflammatory illnesses. A ‘Neutral’ rating was reiterated on EQRx, Inc. (NASDAQ:EQRX) by JPMorgan analyst Chris Schott on August 16. The analyst also placed a $5.50 price target on the stock.

There were 26 hedge funds long EQRx, Inc. (NASDAQ:EQRX) in the second quarter of 2022, with a total stake value of $355.51 million. In comparison, 38 hedge funds were bullish on the stock in the previous quarter, with a total stake value of $494.29 million.

EQRx, Inc. (NASDAQ:EQRX) stands first on the list of top 10 stock picks of Eli Casdin’s Casdin Capital. According to the 13F filings for the second quarter of 2022, the hedge fund held 39.53 million shares of EQRx, Inc. (NASDAQ:EQRX), amounting to more than $185.39 million and representing 15.67% of the fund’s portfolio.

Follow Eqrx Inc.

You can also take a peek at Top 9 Stock Picks of Eduardo Costa’s Calixto Global Investors and Top 10 Stock Picks of Roberto Mignone’s Bridger Management.

Follow Insider Monkey on Twitter

Page 5 of 5